The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Effects of 6 months of abiraterone acetate (AA) on muscle and adipose mass in men with metastatic castration-resistant prostate cancer (mCRPC).
Samuel Craig Brondfield
No relevant relationships to disclose
Vivian K. Weinberg
No relevant relationships to disclose
Kathryn M. Koepfgen
No relevant relationships to disclose
Arturo Molina
Employment or Leadership Position - Ortho Biotech; Ortho Biotech
Stock Ownership - Ortho Biotech
Charles J. Ryan
No relevant relationships to disclose
Eric Jay Small
No relevant relationships to disclose
Andrea Lynne Harzstark
No relevant relationships to disclose